J9298 — Nivolumab 240 Mg-relatlimab-rmbw 80 Mg/20 Ml Intravenous Solution
$46,534
All-payer median here
$59,660
Cash / self-pay here
16
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.